5-(2,4-difluorophenyl)-N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-1,2-oxazole-3-carboxamide
C18H16F2N4O4 — CID 118608819
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(2,4-difluorophenyl)-N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-1,2-oxazole-3-carboxamide
5-(2,4-difluorophenyl)-N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-1,2-oxazole-3-carboxamide (PubChem CID 118608819) has the molecular formula C18H16F2N4O4 and a molecular weight of 390.35 g/mol. Its IUPAC name is 5-(2,4-difluorophenyl)-N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-1,2-oxazole-3-carboxamide.
Molecular Properties
| Compound Name | 5-(2,4-difluorophenyl)-N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-1,2-oxazole-3-carboxamide |
|---|---|
| PubChem CID | 118608819 |
| Molecular Formula | C18H16F2N4O4 |
| Molecular Weight | 390.35 g/mol |
| Exact Mass | 390.11 |
| IUPAC Name | 5-(2,4-difluorophenyl)-N-[3-[5-[(1S)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-1,2-oxazole-3-carboxamide |
| SMILES | C[C@H](O)c1nnc(C2CC(NC(=O)c3cc(-c4ccc(F)cc4F)on3)C2)o1 |
| InChI | InChI=1S/C18H16F2N4O4/c1-8(25)17-22-23-18(27-17)9-4-11(5-9)21-16(26)14-7-15(28-24-14)12-3-2-10(19)6-13(12)20/h2-3,6-9,11,25H,4-5H2,1H3,(H,21,26)/t8-,9?,11?/m0/s1 |
| InChIKey | ZUBWGJHSBXTFQG-SILCLGDVSA-N |
| XLogP | 2.73 |
| TPSA | 114.28 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 390.35 |
| LogP ≤ 5 | 2.73 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118608819 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.